Iridex Q1 FY26 net loss narrows to $0.5 million; revenue slips 1% to $11.8 million

• IRIDEX posted first-quarter revenue of $11.8 million, down 1% from the prior-year period.
• Net loss narrowed to $0.5 million, or $0.03 per share, from $1.7 million, or $0.10 per share, a year earlier.
• Gross margin fell 3 percentage points to 40% on higher manufacturing costs and increased product costs tied to recent tariff developments.
• Cyclo G6 product family revenue climbed 14% to $3.6 million, with probe volume rising to 15,500 from 13,900.
• Full-year 2026 revenue guidance was reaffirmed at $51 million-$53 million, factoring in market disruptions from the Middle East conflict that are affecting delivery timelines.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRIDEX Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-230774), on May 19, 2026, and is solely responsible for the information contained therein.